Stanford Laboratories Private Ltd

Stanford Laboratories Private Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1985PTC022656 Incorporated 29 November 1985 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹178.12 Cr
▲ 3% YoY
Net loss · FY 2025
₹4 Cr
Net margin -2.2%
EBITDA · FY 2025
₹2.18 Cr
EBITDA margin 1.2%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹23.65 Cr
Satisfied ₹5.76 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
301
Provident fund records

About Stanford Laboratories Private Ltd

Data last updated:

Stanford Laboratories Private Ltd is a private limited company based in New Delhi, Delhi, India, a subsidiary of La Renon Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 November 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1985PTC022656. Its GSTIN is 02AABCS3288A1ZV (Himachal Pradesh). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Madhusudan Duggal (Managing Director) and Nihit Duggal.

Its last annual general meeting (AGM) was held on 11 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th Floor Caddie Commercial Tower Aerocity, New Delhi, Delhi, India – 110037.

As per the financials filed for FY 2025, the company reported a revenue of ₹178.12 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹4 Cr (net margin -2.2%) and EBITDA of ₹2.18 Cr (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.

The company has about 301 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Stanford Laboratories. As per MCA filings, the company has open charges of ₹23.65 Cr and satisfied charges of ₹5.76 Cr on record. Court records list 41 cases involving the company, including 12 filed by the company and 29 filed against it; 1 case is pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Mapra Laboratories Pvt Ltd with revenue of ₹184.45 Cr. The company has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers.

Stanford Laboratories Private Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-12-0000885). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stanlabs.com.

Company details

CIN U74899DL1985PTC022656
Registration Number 022656
Incorporation Date 29 November 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company La Renon Healthcare Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-12-0000885

Recognitions & Rankings of Stanford Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-HP-12-0000885

Contact details

Stanford Laboratories Private Ltd's registered office is in New Delhi, Delhi. Its website is stanlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    5th Floor Caddie Commercial Tower Aerocity, New Delhi, Delhi, India – 110037
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Stanford Laboratories Private Ltd, buy the company report.

Comprehensive company report
Stanford Laboratories Private Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Stanford Laboratories operates one associated brand: Stanford Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Acts as a contract manufacturer of pharmaceutical formulations.stanlabs.com

Business activity

The main business activity of Stanford Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Stanford Laboratories Private Ltd, buy the company report.

Financials of Stanford Laboratories Private Ltd

FY 2025 filings available

Stanford Laboratories Private Ltd reported revenue of ₹178.12 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹178.12 Cr ▲ 3%
Net loss · FY 2025
₹4 Cr margin -2.2%
EBITDA · FY 2025
₹2.18 Cr margin 1.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 14%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 75%
3 years · compounded
▼ 26%
5 years · compounded
▼ 26%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 3% growth in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.18 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.2%
Net Profit Margin-2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Stanford Laboratories Private Ltd, buy the company report.

Board of directors of Stanford Laboratories Private Ltd

Stanford Laboratories has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Madhusudan DuggalManaging Director29 Nov 198540 Years 11 MonthsCurrent
Nihit DuggalDirector08 Jun 201511 Years 5 MonthsCurrent
Amit KaushalDirector10 Jul 20251 Years 4 MonthsCurrent
Dilpeshbhai Jagdishbhai ThakkarNominee Director10 Jul 20251 Years 4 MonthsCurrent

Peer comparison

Stanford Laboratories Private Ltd is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mapra Laboratories Pvt Ltd₹184.45 Cr (FY 2025)5.0%Mumbai, Maharashtra, India
Naxpar Pharma Private Limited₹183.89 Cr (FY 2025)1.0%Mumbai, Maharashtra, India
Infutec Healthcare Limited₹183.11 Cr (FY 2021)-22.0%Mumbai, Maharashtra, India
Stanford Laboratories Private Ltdthis company₹178.12 Cr (FY 2025)-₹4 Cr-2.2%3.0%301New Delhi, Delhi, India
BDR Lifesciences Private Limited₹176.87 Cr (FY 2025)-5.0%Vadodara, Gujarat, India
Bakson Drugs and Pharmaceuticals Private Limited₹172.81 Cr (FY 2025)15.0%New Delhi, Delhi, India
Shree Krishnakeshav Laboratories Limited₹170.52 Cr (FY 2025)13.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Stanford Laboratories Private Ltd, buy the company report.

Auditor

Stanford Laboratories Private Ltd is audited by Deloitte Haskins & Sells for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Deloitte Haskins & SellsFY 2024117365W

Shareholding

The shareholding of Stanford Laboratories Private Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Stanford Laboratories Private Ltd, buy the company report.

Charges & borrowings

Open charges
₹23.65 Cr
Satisfied charges
₹5.76 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹23.65 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jun 2017100111338Hdfc Bank Limited₹23.65 CrOpen
08 Feb 201610624175Punjab National Bank₹50 LakhSatisfied
27 Jan 201510549010Punjab National Bank₹50 LakhSatisfied
24 Oct 201310459251Punjab National Bank₹13.75 LakhSatisfied
21 Dec 201210399868State Bank of India₹20 LakhSatisfied

To see the full charge records of Stanford Laboratories Private Ltd, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Stanford Laboratories Private Ltd has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023.

Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹11.5 Lakh

Deals on record (4 of 4)

WhenDealAmountParties
Apr 2023Secondary share transferUndisclosedBuyer: La Renon Healthcare Private Limited , LA Renon Healthcare Private Limited & Abhijit Basu
Seller: La Renon Healthcare Private Limited , 2 individuals
Jun 2015Secondary share transferUndisclosedBuyer: La Renon Healthcare Private Limited
Seller: 2 individuals
Jan 2009Funding round₹11.5 LakhInvestors: 2 individuals
Mar 2008Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Stanford Laboratories Private Ltd has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 92)

SupplierAmount dueDue sinceReported on
S.A. Packaging
Himachal Pharrma Chems
an individual supplier
Caprihans India Limited
Tiwari Pharma Private Limited

To see the full MSME payment records of Stanford Laboratories Private Ltd, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Stanford Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Stanford Lifecare Private LimitedU24304DL2020PTC363402

To see the full group structure of Stanford Laboratories Private Ltd, buy the company report.

Employees & EPFO

Stanford Laboratories Private Ltd has a workforce of 301 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
301
Active EPFO establishments
1
Employee growth
-26.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27301
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Stanford Laboratories Private Ltd, buy the company report.

GST

Stanford Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
02AABCS3288A1ZVHimachal PradeshActive01 Jul 2017
06AABCS3288A1ZNHaryanaActive31 Aug 2017

To see the full GST registrations and return filing status of Stanford Laboratories Private Ltd, buy the company report.

Recent activity

Stanford Laboratories Private Ltd has 14 board changes on record since 1985: 4 appointments and 10 cessations. The latest: Amit Kaushal ceased to be Additional Director on 10 Aug 2025.

AGM
Stanford Laboratories Private Ltd last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records.
Ceased
Amit Kaushal ceased to be Additional Director.
Ceased
Dilpeshbhai Jagdishbhai Thakkar ceased to be Additional Director.
Appointed
Amit Kaushal was appointed as Director.
Appointed
Dilpeshbhai Jagdishbhai Thakkar was appointed as Nominee Director.
Ceased
Neeraj Singh ceased to be Nominee Director.
Filing
Stanford Laboratories Private Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited of Rs. 2,365.20 Lakh registered on 28 Jun 2017 with Charge ID 100111338 was modified on 19 Jul 2023.
Ceased
Abhijit Basu ceased to be Additional Director.
Ceased
Amit Bansilal Jain ceased to be Additional Director.
Ceased
Ankit Shyam ceased to be Nominee Director.
Ceased
Apoorva Singh ceased to be Nominee Director.

25 earlier events are in the company report.

Frequently asked questions

Stanford Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 November 1985 (41+ years old) and is registered under CIN U74899DL1985PTC022656.

Stanford Laboratories has 4 current directors:

The latest financial statements of Stanford Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Stanford Laboratories is 02AABCS3288A1ZV, registered in Himachal Pradesh. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 06AABCS3288A1ZN (Haryana).

The CIN (Corporate Identification Number) of Stanford Laboratories is U74899DL1985PTC022656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stanford Laboratories has 41 court cases on record: 12 filed by the company and 29 filed against it. 1 is pending. Most are in the high courts.

Stanford Laboratories was incorporated on 29 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.

Stanford Laboratories has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023.

The peers of Stanford Laboratories by revenue are Mapra Laboratories Pvt Ltd, Naxpar Pharma Private Limited, Infutec Healthcare Limited, BDR Lifesciences Private Limited, Bakson Drugs and Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Amit Kaushal ceased to be Additional Director on 10 Aug 2025. Dilpeshbhai Jagdishbhai Thakkar ceased to be Additional Director on 10 Aug 2025. Amit Kaushal was appointed as Director on 10 Jul 2025. Stanford Laboratories has 14 board changes on record in total.

Yes, Stanford Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-12-0000885).

Stanford Laboratories has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers. The latest return was filed on 25 Apr 2024.